EOM Pharmaceuticals Holdings, Inc. (IMUC)

OTCMKTS · Delayed Price · Currency is USD
0.0802
-0.0997 (-55.42%)
At close: Feb 27, 2026
-48.92%
Market Cap 10.15M
Revenue (ttm) n/a
Net Income (ttm) -5.13M
Shares Out 126.50M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,736
Average Volume 2,382
Open 0.1797
Previous Close 0.1799
Day's Range 0.0802 - 0.1797
52-Week Range 0.0360 - 0.3399
Beta 1.18
RSI 43.02
Earnings Date n/a

About IMUC

EOM Pharmaceuticals Holdings, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States. The company’s lead compound is EOM613, a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad spectrum cytokine effects that has completed Phase 2 clinical trials for the treatment of cancer cachexia, AIDS/cancer cachexia, HIV/AIDS, and rheumatoid arthritis, as... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol IMUC
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.